Expression and purification of recombinant Kaposi's sarcoma-associated herpesvirus DNA polymerase using a Baculovirus vector system (Q30924314)

27 June 2017

title

Expression and purification of recombinant Kaposi's sarcoma-associated herpesvirus DNA polymerase using a Baculovirus vector system (English)

1 reference

27 June 2017

3

Judy Mikovits

1 reference

27 June 2017

8

Shizuko Sei

1 reference

27 June 2017

Dorjbal Dorjsuren

1

1 reference

27 June 2017

Yunden Badralmaa

2

1 reference

27 June 2017

Aiqun Li

4

1 reference

27 June 2017

Robert Fisher

5

1 reference

27 June 2017

Robert Ricciardi

6

1 reference

27 June 2017

Robert Shoemaker

7

1 reference

27 June 2017

publication date

1 May 2003

1 reference

Protein Expression and Purification

27 June 2017

published in

1 reference

27 June 2017

volume

29

1 reference

27 June 2017

issue

1

1 reference

27 June 2017

page(s)

42-50

1 reference

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

KSHV/HHV8-associated lymphoproliferations in the AIDS setting

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Biology of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Cytomegalovirus infection: the point in 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

New anti-HSV therapeutics target the helicase-primase complex

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Chemical cleavage at aspartyl residues for protein identification

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

Functional characterization of partially purified Epstein-Barr virus DNA polymerase expressed in the baculovirus system

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

A rapid plate assay for the screening of inhibitors against herpesvirus DNA polymerases and processivity factors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-5928%2803%2900017-2

7 January 2021

10.1016/S1046-5928(03)00017-2

Identifiers

DOI

1 reference

27 June 2017

1 reference